V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10398833 | 10064860 | 1.52 | 94.9 | 03 | 2020-06-13 | 2020-06-15 | Gefitinib: 1 to 2 & 4 onwards | 02 | N | BCG | 101614998 |
| 10399749 | 10064862 | 1.62 | 69.1 | null | 2018-02-27 | 2019-02-25 | GEFITINIB | 02 | null | PENTOSTATIN + RITUXIMAB | 101135681 |
| 10399803 | 10064863 | 1.83 | 88.3 | Palliative (P) | 2019-12-10 | 2019-12-18 | Nintedanib | 02 | N | PEG INTERFERON ALFA | 100479259 |
| 10400222 | 10064865 | 1.74 | 109 | Palliative (P) | 2019-03-06 | 2019-03-06 | Durvalumab | N | N | LANREOTIDE | 101630281 |
| 10400302 | 10064866 | null | null | null | null | 2019-09-09 | Capecitabine (14 days)+Carboplatin | null | null | ANAGRELIDE | 100044789 |
| 10400896 | 10064867 | 1.73 | 90 | Not known (9) | 2018-12-21 | 2019-01-20 | Folfirinox | 02 | N | NOT MATCHED | 101530882 |
| 10401630 | 10064868 | 1.75 | 70.5 | null | 2021-11-02 | 2021-11-25 | null | 02 | null | BOSUTINIB | 100554886 |
| 10402166 | 10064872 | 1.72 | 90.8 | null | 2017-11-05 | 2018-01-28 | PERSEPHONE TRIAL | null | null | LORLATINIB | 100589648 |
| 10402271 | 10064873 | null | null | null | null | 2020-09-05 | CARBOPLATIN + DOCETAXEL + Pertuzumab + Trastuzumab | 02 | null | MATRIX LYMPHOMA TRIAL | 100145504 |
| 10402355 | 10064874 | null | null | Palliative (P) | 2022-05-07 | 2022-05-14 | LORLATINIB | 02 | N | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 100699286 |
| 10402433 | 10064875 | null | null | null | 2018-04-07 | 2018-06-18 | Cyclophos + Dex + Lenalidomide | 02 | null | TIVOZANIB | 101657710 |
| 10402629 | 10064878 | null | null | null | 2021-09-02 | 2021-09-26 | Trial Unspecified | 02 | null | SORAFENIB | 100711099 |
| 10403107 | 10064879 | 1.69 | 0 | 03 | 2017-12-27 | 2018-01-17 | null | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101573942 |
| 10403126 | 10064880 | null | null | null | 2019-02-08 | 2019-05-09 | Pertuzumab (Maintenance) | 02 | null | BEAM | 100034244 |
| 10403607 | 10064882 | null | null | Palliative (P) | 2020-11-02 | 2021-11-04 | Pertuzumab (Loading) | 02 | N | CARBOPLATIN + PACLITAXEL + PEMBROLIZUMAB | 100177845 |
| 10404140 | 10064884 | null | null | null | 2016-10-01 | 2016-10-02 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | null | null | ATEZOLIZUMAB + CARBOPLATIN + ETOPOSIDE | 101849160 |
| 10404166 | 10064885 | 1.66 | 64 | null | 2020-10-07 | 2020-10-07 | Irinotecan 14day | 02 | null | DASATINIB | 100306446 |
| 10404444 | 10064886 | 1.88 | null | Adjuvant (A) | 2020-05-19 | 2020-05-21 | Ipilimumab | 02 | N | CHOP R | 101732737 |
| 10404552 | 10064887 | 1.83 | 87 | null | null | 2017-08-17 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | null | BRENTUXIMAB | 100479681 |
| 10404614 | 10064888 | null | null | Adjuvant (A) | null | 2019-04-17 | R GDP | N | N | LOMUSTINE + PROCARBAZINE | 101714696 |
| 10405042 | 10064889 | 1.56 | 57 | null | 2017-10-06 | 2017-11-03 | DOCETAXEL + GEMCITABINE | null | null | METHOTREXATE INTRATHECAL | 101692462 |
| 10405190 | 10064890 | null | null | null | 2018-04-08 | 2018-04-08 | Capecitabine + Trastuzumab | 01 | null | DOXORUBICIN | 100121130 |
| 10405555 | 10064891 | null | null | Curative (C) | null | 2017-05-24 | NEPTUNE TRIAL | 02 | N | TRASTUZUMAB EMTANSINE | 101650779 |
| 10405823 | 10064892 | null | null | Neo-adjuvant (N) | null | 2020-10-26 | Cyclophosphamide Fludarabine (Oral) | 02 | null | GEMCITABINE + PACLITAXEL | 101016992 |
| 10405992 | 10064893 | 1.65 | null | null | 2018-09-18 | 2018-10-01 | Cyclophosphamide+Fludara+TBI Allo | null | null | ANTI-THYMOCYTE GLOBULIN + BUSULFAN + FLUDARABINE | 101791626 |
| 10406018 | 10064894 | null | null | 03 | null | 2019-05-02 | Cladribine (subcut) 5 days | 02 | N | OBINUTUZUMAB | 100181934 |
| 10406321 | 10064896 | 1.78 | 94.6 | 03 | 2018-07-08 | 2018-07-08 | PCV | N | N | DOXORUBICIN | 101299104 |
| 10407673 | 10064898 | 1.9 | 65 | Palliative (P) | 2017-08-15 | 2017-08-23 | Capecitabine (14 days)+Carboplatin | 01 | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 101636867 |
| 10408403 | 10064899 | null | null | null | 2020-01-01 | 2020-01-02 | Sunitinib | 02 | null | OXALIPLATIN + MDG | 101029680 |
| 10408442 | 10064900 | 1.7 | 74.6 | null | 2019-06-22 | 2021-01-31 | CAPECITABINE + MITOMYCIN + RT | 02 | null | ARSENIC TRIOXIDE + TRETINOIN | 100540929 |
| 10408658 | 10064901 | 1.75 | 71.8 | null | 2019-11-07 | 2019-11-21 | BEAM | 02 | null | BINIMETINIB + ENCORAFENIB | 101204875 |
| 10408909 | 10064902 | null | null | null | null | 2018-07-05 | Pertuzumab (Maintenance) | null | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 101262958 |
| 10408967 | 10064903 | 1.57 | 84.6 | 03 | 2018-08-14 | 2018-10-02 | Carboplatin + Liposomal Doxorubicin | 02 | N | IRINOTECAN + RALTITREXED | 100864006 |
| 10409217 | 10064904 | null | null | Palliative (P) | 2017-05-30 | 2017-06-10 | Lomustine | N | N | PENTOSTATIN | 101473163 |
| 10409363 | 10064905 | null | null | Palliative (P) | 2019-05-01 | 2019-06-29 | INTERFERON | null | N | OSIMERTINIB | 101422272 |
| 10409542 | 10064907 | null | null | null | 2020-08-25 | 2020-08-26 | CHOP | 02 | null | CHLORAMBUCIL + PROCARBAZINE + VINBLASTINE | 100586671 |
| 10409639 | 10064908 | 1.81 | 70.6 | null | null | 2016-11-28 | FLAIR trial | null | null | APALUTAMIDE | 101660794 |
| 10409940 | 10064909 | 1.73 | 68.7 | null | null | 2021-05-13 | BLEOMYCIN | 02 | null | MELPHALAN + THALIDOMIDE | 101609885 |
| 10410025 | 10064910 | 1.67 | 83.6 | null | 2019-06-11 | 2019-07-02 | Oxaliplatin + Modified de Gramont | null | null | VEDEX | 101209874 |
| 10410368 | 10064911 | 1.52 | 78.1 | Palliative (P) | 2017-01-19 | 2017-01-20 | Ipilimumab | N | N | TRABECTEDIN | 100153451 |
| 10410422 | 10064912 | 1.57 | 77 | null | 2021-03-15 | 2021-03-31 | Sunitinib | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB | 101161472 |
| 10410612 | 10064913 | 0 | 130 | Neo-adjuvant (N) | 2019-07-20 | 2019-07-24 | FLAIR trial | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101686065 |
| 10410684 | 10064914 | 1.76 | 78.9 | Curative (C) | 2018-03-01 | 2018-04-12 | Folfirinox | 02 | Y | CHLORAMBUCIL + OFATUMUMAB | 100401278 |
| 10410827 | 10064915 | 0 | 41 | Disease modification (D) | 2020-03-08 | 2020-03-08 | Sunitinib | 02 | N | CAPECITABINE + MITOMYCIN | 101432799 |
| 10410951 | 10064916 | null | null | Adjuvant (A) | 2019-08-18 | 2019-08-18 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | N | BEVACIZUMAB | 100557383 |
| 10411344 | 10064917 | null | null | null | 2020-09-12 | 2020-10-25 | Gemcitabine + Oxaliplatin | 02 | null | ANAGRELIDE | 101332368 |
| 10411609 | 10064918 | 1.72 | 105 | null | 2018-08-18 | 2018-08-18 | Cytarabine High Dose | null | null | BCG | 101515451 |
| 10411732 | 10064919 | 1.68 | 83 | Palliative (P) | 2019-01-01 | 2019-01-01 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | FLUOROURACIL + MITOMYCIN | 100791723 |
| 10411984 | 10064920 | null | null | 03 | 2016-11-20 | 2016-12-03 | null | 02 | Y | BLEOMYCIN + CYCLOPHOSPHAMIDE + ETOPOSIDE + MITOXANTRONE + RITUXIMAB + VINCRISTINE | 101140401 |
| 10412256 | 10064924 | null | null | Not known (9) | 2017-07-03 | 2019-12-23 | Carboplatin + Docetaxel | null | N | MELPHALAN + THALIDOMIDE | 101807502 |